Assessing the impact of deep-learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes.

Autor: Bogaerts JM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Steenbeek MP; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., Bokhorst JM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van Bommel MH; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., Abete L; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Addante F; Pathology Unit, Department of Woman and Child's Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Brinkhuis M; Department of Pathology, LabPON, Hengelo, The Netherlands., Chrzan A; Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Cordier F; Department of Pathology, Ghent University Hospital, Ghent, Belgium., Devouassoux-Shisheboran M; Department of Pathology, Hospices Civils de Lyon, Lyon, France., Fernández-Pérez J; Department of Pathology, University Hospital Virgen de la Arrixaca, Murcia, Spain., Fischer A; Institute for Pathology and Neuropathology, University of Tuebingen Medical Center II, Tuebingen, Germany., Gilks CB; Department of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, Canada., Guerriero A; General Pathology and Cytopathology Unit, Department of Medicine-DMED, University of Padua, Padua, Italy., Jaconi M; Department of Pathology, San Gerardo Hospital, Monza, Italy., Kleijn TG; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., Kooreman L; Department of Pathology, and GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands., Martin S; Department of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, Canada., Milla J; Institute for Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany., Narducci N; Pathology Department, Ospedale dell'Angelo, Venezia-Mestre, Italy., Ntala C; Department of Pathology, St. George's University Hospitals, London, UK., Parkash V; Department of Pathology, Yale School of Medicine and Yale School of Public Health, New Haven, CT, USA., de Pauw C; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Rabban JT; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Rijstenberg L; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Rottscholl R; Institute for Pathology and Neuropathology, University of Tuebingen Medical Center II, Tuebingen, Germany., Staebler A; Institute for Pathology and Neuropathology, University of Tuebingen Medical Center II, Tuebingen, Germany., Van de Vijver K; Department of Pathology, Cancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent, Belgium., Zannoni GF; Pathology Unit, Department of Woman and Child's Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., van Zanten M; Department of Pathology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., de Hullu JA; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., Simons M; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Laak JA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden.

Publikováno v: The journal of pathology. Clinical research [J Pathol Clin Res] 2024 Nov; Vol. 10 (6), pp. e70006.

Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy.

Autor: van den Berg CB; Department of Gynecologic Oncology, Erasmus MC Cancer Center, University Medical Center, Rotterdam, the Netherlands. Electronic address: c.vandenberg@erasmusmc.nl., Dasgupta S; Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands; Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, United States., Ewing-Graham PC; Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., Bart J; Department of Pathology, University Medical Center Groningen, University of Groningen, the Netherlands., Bulten J; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Gaarenstroom KN; Department of Gynecologic Oncology, Leiden University Medical Center, Leiden, the Netherlands., de Hullu JA; Department of Gynecologic Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Mom CH; Department of Gynecologic Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, Center for Gynecologic Oncology Amsterdam, the Netherlands., Mourits MJE; Department of Gynecologic Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Steenbeek MP; Department of Gynecologic Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., van Marion R; Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., van Beekhuizen HJ; Department of Gynecologic Oncology, Erasmus MC Cancer Center, University Medical Center, Rotterdam, the Netherlands.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 113-119. Date of Electronic Publication: 2024 May 17.

Consensus based recommendations for the diagnosis of serous tubal intraepithelial carcinoma: an international Delphi study.

Autor: Bogaerts JMA; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., van Bommel MHD; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands., Hermens RPMG; IQ Healthcare, Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Steenbeek MP; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands., de Hullu JA; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands., van der Laak JAWM; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.; Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden., Simons M; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.

Publikováno v: Histopathology [Histopathology] 2023 Jul; Vol. 83 (1), pp. 67-79. Date of Electronic Publication: 2023 Mar 20.

Reply to J. Zhang et al.

Autor: Steenbeek MP; Miranda P. Steenbeek, MD, PhD, and Majke H.D. van Bommel, MD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands; Johan Bulten, MD, PhD, Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands; Rosella P.M.G. Hermens, PhD, Radboud University Medical Center, Scientific Institute for Quality of Healthcare, Nijmegen, the Netherlands; Joanna IntHout, PhD, Radboud University Medical Center, Department for Health Evidence, Nijmegen, the Netherlands; and Joanne A. de Hullu, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., van Bommel MHD; Miranda P. Steenbeek, MD, PhD, and Majke H.D. van Bommel, MD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands; Johan Bulten, MD, PhD, Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands; Rosella P.M.G. Hermens, PhD, Radboud University Medical Center, Scientific Institute for Quality of Healthcare, Nijmegen, the Netherlands; Joanna IntHout, PhD, Radboud University Medical Center, Department for Health Evidence, Nijmegen, the Netherlands; and Joanne A. de Hullu, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., Bulten J; Miranda P. Steenbeek, MD, PhD, and Majke H.D. van Bommel, MD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands; Johan Bulten, MD, PhD, Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands; Rosella P.M.G. Hermens, PhD, Radboud University Medical Center, Scientific Institute for Quality of Healthcare, Nijmegen, the Netherlands; Joanna IntHout, PhD, Radboud University Medical Center, Department for Health Evidence, Nijmegen, the Netherlands; and Joanne A. de Hullu, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., Hermens RPMG; Miranda P. Steenbeek, MD, PhD, and Majke H.D. van Bommel, MD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands; Johan Bulten, MD, PhD, Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands; Rosella P.M.G. Hermens, PhD, Radboud University Medical Center, Scientific Institute for Quality of Healthcare, Nijmegen, the Netherlands; Joanna IntHout, PhD, Radboud University Medical Center, Department for Health Evidence, Nijmegen, the Netherlands; and Joanne A. de Hullu, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., IntHout J; Miranda P. Steenbeek, MD, PhD, and Majke H.D. van Bommel, MD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands; Johan Bulten, MD, PhD, Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands; Rosella P.M.G. Hermens, PhD, Radboud University Medical Center, Scientific Institute for Quality of Healthcare, Nijmegen, the Netherlands; Joanna IntHout, PhD, Radboud University Medical Center, Department for Health Evidence, Nijmegen, the Netherlands; and Joanne A. de Hullu, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., de Hullu JA; Miranda P. Steenbeek, MD, PhD, and Majke H.D. van Bommel, MD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands; Johan Bulten, MD, PhD, Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands; Rosella P.M.G. Hermens, PhD, Radboud University Medical Center, Scientific Institute for Quality of Healthcare, Nijmegen, the Netherlands; Joanna IntHout, PhD, Radboud University Medical Center, Department for Health Evidence, Nijmegen, the Netherlands; and Joanne A. de Hullu, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Nov 10; Vol. 40 (32), pp. 3783-3784. Date of Electronic Publication: 2022 Jul 12.

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors.

Autor: van Bommel MHD; Department of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. Majke.vanBommel@radboudumc.nl., Steenbeek MP; Department of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., IntHout J; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Hermens RPMG; Scientific Institute for Quality of Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Hoogerbrugge N; Department of Human Genetics, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Harmsen MG; Department of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van Doorn HC; Department of Gynaecology, Erasmus MC Cancer Clinic, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands., Mourits MJE; Department of Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., van Beurden M; Center for Gynaecological Oncology Amsterdam (CGOA), Netherlands Cancer Institute/Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Zweemer RP; Department of Gynaecological Oncology, UMC Utrecht Cancer Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Gaarenstroom KN; Department of Obstetrics and Gynaecology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Slangen BFM; Department of Obstetrics and Gynaecology, Maastricht University Medical Center, GROW-School for Oncology and Developmental Biology, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands., Brood-van Zanten MMA; Center for Gynaecological Oncology Amsterdam (CGOA), Netherlands Cancer Institute/Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Center for Gynaecological Oncology Amsterdam (CGOA), AmsterdamUMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Vos MC; Gynaecologic Oncologic Center South Location Elisabeth-TweeSteden Hospital, Hilvarenbeekseweg 60, 5000 LC, Tilburg, The Netherlands., Piek JM; Gynaecologic Oncologic Center South Location Catharina Hospital, Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands., van Lonkhuijzen LRCW; Center for Gynaecological Oncology Amsterdam (CGOA), AmsterdamUMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Apperloo MJA; Department of Obstetrics and Gynaecology, Medical Center Leeuwarden, Henri Dunantweg 2, 8934 AD, Leeuwarden, The Netherlands., Coppus SFPJ; Department of Obstetrics and Gynaecology, Maxima Medical Center, De Run 4600, 5504 DB, Veldhoven, The Netherlands., Prins JB; Department of Medical Psychology, Radboud Institute F Or Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Custers JAE; Department of Medical Psychology, Radboud Institute F Or Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Hullu JA; Department of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Apr; Vol. 30 (4), pp. 3409-3418. Date of Electronic Publication: 2022 Jan 08.